Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: A preliminary prospective study

Clinical Microbiology and Infection

Volumn 17, Issue 6, 2011, Pages 836-844

  Bensimhon, L ^a   Lavergne, T ^a   Hugonnet, F ^a   Mainardi, J L ^a   Latremouille, C ^a   Maunoury, C ^a   Lepillier, A ^a   Le Heuzey, J Y ^a   Faraggi, M ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Infection; Pacemaker; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; BACTERIOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; ECHOCARDIOGRAPHY; HUMAN; PACEMAKER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; WHOLE BODY PET;

EID: 79959296181     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03312.x     Document Type: Article

References (16)

1. Klug D, Balde M, Pavin D et al. Risk factors related to infections of implanted pace maker and cardioverter defibrillator, results of a large prospective study. Circulation 2007; 116: 1349-1355.
2. Costa A, Kirkorian G, Chevalier PH, Cerisier A, Chalvidan T, Obadia J-F. Infectious complications of pacemaker implantation. Arch Mal Coeur Vaiss 1998; 91: 753-757.
3. Lauck G, Hagendorff A, Omran H et al. Sessile structures on implanted leads of cardiac pacemakers. Eur Heart J 1994; 15: 58-59.
4. Kalicke T, Schmitz A, Risse JH et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27: 524-528.
5. Fukuchi K, Ishida Y, Higashi M et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg 2005; 42: 919-925.
6. Kraemer WJ, Saplys R, Waddell JP, Morton J. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J Arthroplasty 1993; 8: 611-616.
7. Bakheet S, Powe P, Ezaat A, Rostom A. 18 FDG uptake in tuberculosis. Clin Nucl Med 1998; 23: 739-742.
8. Bleeker-Rovers CP, Bredie SJ, Van der Meer JW, Corstens FH, Oyen WJ. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 2003; 61: 323-329.
9. Keidar Z, Nitecki S. FDG-PET for the detection of infected vascular grafts. Q J Nucl Med Mol Imaging 2009; 53: 35-40.
10. Li JS, Sexton DJ, Mick N et al. Proposed modification for the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.
11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
12. Vos FJ, Bleeker-Rovers CP, Van Dijk APJ, Oyen WJG. Detection of pacemaker and lead infection with FDG PET. Eur J Nucl Med Mol Imaging 2006; 33: 1245-1247.
13. 18FDG PET. J Cardiovasc Electrophysiol 2008; 19: 1327-1328.
14. Abikhzer G, Turpin S, Bigras JL. Infected pacemaker causing septic lung emboli detected on FDG PET/CT. J Nucl Cardiol 2009; 16: 1532-1535.
15. Farsad M, Pernter P, Triani A, Osele L, Wiedermann CJ. Thromboembolism in pulmonary artery sarcoma. Clin Nucl Med 2009; 34: 239-240.
16. Akin E, Coen A, Momeni M. PET-CT findings in large vessel vasculitis presenting as FUO, a case report. Clin Rheumatol 2009; 28: 737-738.